• Je něco špatně v tomto záznamu ?

Lethal suicide attempt with a mixed-drug intoxication of metoprolol and propafenone - A first pediatric case report

I. Kacirova, M. Grundmann, M. Kolek, E. Vyskocilova-Hrudikova, R. Urinovska, P. Handlos,

. 2017 ; 278 (-) : e34-e40. [pub] 20170629

Jazyk angličtina Země Irsko

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18033825
E-zdroje Online Plný text

NLK ProQuest Central od 1997-02-07 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest) od 1997-02-07 do Před 2 měsíci
Health & Medicine (ProQuest) od 1997-02-07 do Před 2 měsíci

INTRODUCTION: The β1 adrenergic receptor blocker metoprolol is often prescribed together with the antiarrhythmic drug propafenone. Both are metabolized by cytochrome P450 2D6 and propafenone is also an inhibitor of this enzyme. We present a pediatric case showing metoprolol and propafenone intoxication in combination. CASE: A 14-year-old girl was admitted to a local emergency department after ingestion of metoprolol (probably 1g) and propafenone (probably 1.5-3g) in a suicide attempt. She developed cardiogenic shock with cardiac arrest and was fully resuscitated. Veno-arterial femorofemoral extracorporeal membrane oxygenation was started immediately. High serum levels of both drugs were detected approximately 10h after ingestion (2630ng/mL metoprolol and 2500ng/mL propafenone). Other serial samples for the monitoring of the levels of metoprolol and its metabolite alfa-hydroxymetoprolol were obtained between days 2 and 4 after admission. The metoprolol/alfa-hydroxymetoprolol ratio on the 2nd day was 36.1, indicative of a poor metabolizer phenotype. The elimination half-life of metoprolol was prolonged to 13.2h and the clearance decreased by about 70%. The patient condition gradually worsened, brain edema and intracerebral hemorrhage occurred, and on the 6th day, the patient died. CONCLUSION: We document a pediatric case report of death due to a mixed drug overdose of metoprolol and propafenone, along with data regarding serum metoprolol, alfa-hydroxymetoprolol, and propafenone levels.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033825
003      
CZ-PrNML
005      
20181016135608.0
007      
ta
008      
181008s2017 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.forsciint.2017.06.025 $2 doi
035    __
$a (PubMed)28716517
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Kacirova, Ivana $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic; Department of Clinical Pharmacology, Department of Laboratory Diagnostics, University Hospital Ostrava, Ostrava, Czech Republic.
245    10
$a Lethal suicide attempt with a mixed-drug intoxication of metoprolol and propafenone - A first pediatric case report / $c I. Kacirova, M. Grundmann, M. Kolek, E. Vyskocilova-Hrudikova, R. Urinovska, P. Handlos,
520    9_
$a INTRODUCTION: The β1 adrenergic receptor blocker metoprolol is often prescribed together with the antiarrhythmic drug propafenone. Both are metabolized by cytochrome P450 2D6 and propafenone is also an inhibitor of this enzyme. We present a pediatric case showing metoprolol and propafenone intoxication in combination. CASE: A 14-year-old girl was admitted to a local emergency department after ingestion of metoprolol (probably 1g) and propafenone (probably 1.5-3g) in a suicide attempt. She developed cardiogenic shock with cardiac arrest and was fully resuscitated. Veno-arterial femorofemoral extracorporeal membrane oxygenation was started immediately. High serum levels of both drugs were detected approximately 10h after ingestion (2630ng/mL metoprolol and 2500ng/mL propafenone). Other serial samples for the monitoring of the levels of metoprolol and its metabolite alfa-hydroxymetoprolol were obtained between days 2 and 4 after admission. The metoprolol/alfa-hydroxymetoprolol ratio on the 2nd day was 36.1, indicative of a poor metabolizer phenotype. The elimination half-life of metoprolol was prolonged to 13.2h and the clearance decreased by about 70%. The patient condition gradually worsened, brain edema and intracerebral hemorrhage occurred, and on the 6th day, the patient died. CONCLUSION: We document a pediatric case report of death due to a mixed drug overdose of metoprolol and propafenone, along with data regarding serum metoprolol, alfa-hydroxymetoprolol, and propafenone levels.
650    _2
$a mladiství $7 D000293
650    _2
$a antagonisté beta-1-adrenergních receptorů $x krev $x otrava $7 D058671
650    _2
$a antiarytmika $x krev $x otrava $7 D000889
650    _2
$a edém mozku $x chemicky indukované $7 D001929
650    _2
$a cerebrální krvácení $x chemicky indukované $7 D002543
650    _2
$a lékové interakce $7 D004347
650    _2
$a předávkování léky $7 D062787
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční zástava $x chemicky indukované $7 D006323
650    _2
$a lidé $7 D006801
650    _2
$a metoprolol $x krev $x otrava $7 D008790
650    _2
$a propafenon $x krev $x otrava $7 D011405
650    _2
$a kardiogenní šok $x chemicky indukované $7 D012770
650    12
$a sebevražda $7 D013405
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Grundmann, Milan $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Electronic address: milan.grundmann@osu.cz.
700    1_
$a Kolek, Martin $u Department of Cardiac Surgery, University Hospital Ostrava, Ostrava, Czech Republic.
700    1_
$a Vyskocilova-Hrudikova, Erika $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic; Department of Clinical Pharmacology, Department of Laboratory Diagnostics, University Hospital Ostrava, Ostrava, Czech Republic.
700    1_
$a Urinovska, Romana $u Department of Clinical Pharmacology, Department of Laboratory Diagnostics, University Hospital Ostrava, Ostrava, Czech Republic.
700    1_
$a Handlos, Petr $u Department of Forensic Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
773    0_
$w MED00001844 $t Forensic science international $x 1872-6283 $g Roč. 278, č. - (2017), s. e34-e40
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28716517 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181016140105 $b ABA008
999    __
$a ok $b bmc $g 1340989 $s 1030819
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 278 $c - $d e34-e40 $e 20170629 $i 1872-6283 $m Forensic science international $n Forensic Sci Int $x MED00001844
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...